Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $168.90 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $36.93 | 3 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $34.64 | 2 | $0 (2017) |
| Allergan Inc. | $19.33 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $17.12 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $15.91 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $15.83 | 1 | $0 (2019) |
| AbbVie Inc. | $15.46 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $13.68 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $31.37 | 2 | Janssen Biotech, Inc. ($15.91) |
| 2019 | $15.83 | 1 | Janssen Pharmaceuticals, Inc ($15.83) |
| 2018 | $33.01 | 2 | Allergan Inc. ($19.33) |
| 2017 | $88.69 | 6 | Merck Sharp & Dohme Corporation ($36.93) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/08/2023 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Immunology | ||||||
| 08/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/24/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/10/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/31/2017 | Valeant Pharmaceuticals North America LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/20/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/23/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/03/2017 | Valeant Pharmaceuticals North America LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/30/2017 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardio-pulmonary | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 643 | 984 | $253,828 | $82,743 |
| 2022 | 6 | 682 | 1,065 | $238,068 | $75,023 |
| 2021 | 5 | 709 | 1,150 | $252,076 | $82,170 |
| 2020 | 6 | 787 | 1,281 | $259,666 | $91,578 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 207 | 483 | $109,655 | $40,969 | 37.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 148 | 150 | $69,750 | $18,299 | 26.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 138 | 140 | $23,380 | $7,938 | 34.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 76 | 128 | $20,224 | $6,954 | 34.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 27 | $16,105 | $4,227 | 26.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 35 | 35 | $8,120 | $2,758 | 34.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 21 | $6,594 | $1,597 | 24.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 162 | 383 | $86,955 | $28,647 | 32.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 167 | 324 | $51,192 | $16,522 | 32.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 94 | 96 | $43,678 | $12,843 | 29.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 94 | 94 | $28,958 | $8,075 | 27.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 153 | 156 | $24,657 | $8,015 | 32.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 12 | 12 | $2,628 | $921.90 | 35.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 187 | 472 | $107,144 | $35,016 | 32.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 168 | 315 | $49,770 | $16,425 | 33.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 78 | 82 | $35,998 | $11,457 | 31.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 103 | 107 | $31,672 | $10,091 | 31.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 173 | 174 | $27,492 | $9,180 | 33.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 223 | 532 | $113,848 | $40,759 | 35.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 213 | 392 | $58,408 | $21,244 | 36.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 74 | 75 | $31,050 | $10,632 | 34.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 176 | 181 | $26,969 | $9,792 | 36.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 89 | 89 | $24,831 | $7,897 | 31.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 12 | 12 | $4,560 | $1,254 | 27.5% |
About Dr. Brandy Utter, MD
Dr. Brandy Utter, MD is a Family Medicine healthcare provider based in Shoreview, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255468914.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brandy Utter, MD has received a total of $168.90 in payments from pharmaceutical and medical device companies, with $31.37 received in 2023. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($168.90).
As a Medicare-enrolled provider, Utter has provided services to 2,821 Medicare beneficiaries, totaling 4,480 services with total Medicare billing of $331,514. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Shoreview, MN
- Active Since 02/28/2007
- Last Updated 12/05/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255468914
Products in Payments
- RELISTOR (Drug) $34.64
- AVYCAZ (Drug) $19.33
- Adempas (Drug) $17.12
- SIMPONI ARIA (Biological) $15.91
- XARELTO (Drug) $15.83
- DALVANCE (Drug) $15.46
- DIFICID (Drug) $13.80
- BRILINTA (Drug) $13.68
- JANUVIA (Drug) $12.47
- ZERBAXA (Drug) $10.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shoreview
Bruce Leppink, Md, MD
Family Medicine — Payments: $1,056
Matthew Monteiro, Md, MD
Family Medicine — Payments: $234.95
Cynthia Frane, Md, MD
Family Medicine — Payments: $104.13
Christian Anderson, Md, MD
Family Medicine — Payments: $46.85
Anne Campbell, Md, MD
Family Medicine — Payments: $15.34
Lizabeth Kaku, Md, MD
Family Medicine — Payments: $7.85